Dr. Thomas W. Pendergrass

powered by
COS Expertise®
University of Washington
School of Medicine
Pediatrics
Associate ProfessorAppointed: 1984
University of Washington
School of Medicine
Pediatrics
Educational Affairs
Vice ChairAppointed: 1989
Fred Hutchinson Cancer Research Center
Clinical Research Division
Professional Headshot of Thomas W. Pendergrass

Mailing Address

Children's Hospital and Regional Medical Center
P.O. Box 5371, CH-03
Seattle, Washington 98105
United States

Contact Information

Phone: (206) 526-2526
Fax: (206) 528-5022
tpende@chmc.org

Qualifications

M.S.P.H., University of Washington, Epidemiology, 1979.
M.D., University of Tennessee - Knoxville, Medicine, 1971.

Expertise and Research Interests

Therapy and epidemiology:
pediatric oncology and hematology;
bone and soft tissue sarcomas;
retinoblastoma;
pediatric leukemias;
pediatric lymphoma;
Wilms' tumor;
neuroblastoma;
pediatric liver malignancies;
pediatric brain tumors;
late effects of cancer treatment.

Pediatrics:
management of childhood illnesses and health;
health care delivery systems.

Medical education:
pediatric curriculum;
evaluation;
residency program management;
continuing medical education.

Keywords

COS Keywords:

Bone Marrow Transplantation, Brain Tumors, Cell Biology, Epidemiology, Growth Factors, Health Services Delivery, Hematology, Immunology, Leukemia, Medical Education, Oncology, Pediatrics.

Additional Terms:

Cancer Chemotherapy, Epidemiology, Growth Factors, Late Effects of Cancer Treatment, New Anticancer Agents, Pediatric Hematology, Pediatric Oncology.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)

Memberships

American Academy of Pediatrics

Honors and Awards

2000, Voices for Children, The Children's Alliance and Washington Chapter, American Academy of Pediatrics, Outstanding Advocate for Year 2000
2000, Seattle's 350 Best Doctors, Seattle Magazine, Pediatric Hematology/Oncology
1996, The Best Doctors in America: Pacific Region, Woodward/White, Inc
1995, Pediatric Teaching Award, Ambulatory Pediatric Association, “The Pediatric WAMI Program”

Publications

  • Reaman GH, Sposto R, Sensel MG, Lange BJ, Fuesner J, Heerema NA, Leonard M, Holmes E, Sather HN, Pendergrass T, Johnstone H, O’Brien R, Steinherz P, Zeltzer P, Gaynon P, Trigg M, Uckum F, Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on consecutive trials of the Children’s Cancer Group, Journal of Clinical Oncology, 445-455, 1999
  • Buckley JD, Pendergrass TW, Buckley CM, Pritchard DJ, Nesbit ME, Provisor AJ, Robison LL, Epidemiology of Osteosarcoma and Ewing’s Sarcoma in Childhood: A study of 305 cases from the Children’s Cancer Group, Cancer, 83, 1440-1448, 1998
  • Olson JE, Shu XO, Ross JA, Pendergrass TW, Robison LL, Medical record validation of maternal-reported questionnaire birth characteristics and pregnancy-related events: A report from the Childrens Cancer Group, American Journal of Epidemiology, 145, 58-67, 1997
  • Moscinski L C, Pendergrass T W, Weiss A, Hvizdala E, Buckley K S, Kalina R E, Recommendations for the use of routine bone marrow aspiration and lumbar punctures in the follow-up of patients with retinoblastoma., Journal of Pediatric hematology/oncology, 18(2), 130-4, May 1996 Abstract
  • Shu XO, Ross JA, Pendergrass TW, Reaman GH, Lampkin B, Robison LL, Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: A Childrens Cancer Group Study, Journal of the National Cancer Institute, 88, 24-31, 1996
  • Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL, Maternal exposure to potential inhibitors of DNA topoisomerase II and risk of infant leukemia (United States): A report from the Childrens Cancer Group, Cancer Causes and Control, 7, 581-590, 1996
  • Feig SA, Ames MM, Sather HN, Steinherz L, Reid JM, Trigg M, Pendergrass TW, Warkentin P, Gerber M, Leonard M, Bleyer WA, Harris RE, Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Childrens Cancer Group, Medical and Pediatric Oncology, 27, 505-514, 1996
  • Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL, Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia: A report of the Children’s Cancer Study Group, Cancer Causes and Control, 7, 581-590, 1996
  • Weiss A H, Karr D J, Kalina R E, Lindsley K L, Pendergrass T W, Visual outcomes of macular retinoblastoma after external beam radiation therapy., Ophthalmology, 101(7), 1244-9, July 1994 Abstract
  • Felgenhauer J, Hawkins D, Pendergrass T, Lindsley K, Conrad EU, Miser JS, Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas, Medical and Pediatric Oncology, 34, 29-38

Profile Details

Last Updated: 6/6/2001

COS Expertise ID #307806
Reference this profile directly: http://myprofile.cos.com/pendergt06